Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
rigorous safety standards. This is a commonsense reform that will increase competition, expand patient choice, and help reduce … Langworthy and Schrier for introducing this bipartisan, commonsense reform that will break market monopolies, expand therapeutic choices